Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

Older adults can continue getting covid boosters, but not everyone who wants them can. You’re reading The Checkup With Dr.

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

In a major policy change, the Food and Drug Administration has announced a plan to limit access to future COVID-19 shots only ...

The changes by the FDA mean restricting access to who can get seasonal COVID shots—limiting approval to seniors over 65, ...

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around the ...

The FDA will continue recommending annual COVID-19 vaccines for older adults and high-risk groups, but says more clinical ...

The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...

FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and ...

"The FDA will approve vaccines for high ... understand age- and risk-based recommendations. We reject this view," they wrote. The new "regulatory framework for COVID-19 vaccination" laid out ...